BOSTON--(EON: Enhanced Online News)--ONEighty oC Technologies Corporation www.ONEightyC.com, founded in 2013, is a Massachusetts-based developer and provider of cost-effective, turnkey sterilization product solutions for the health and security markets. The Company owns a commercialized and patented technology designed to have superior sterilization performance.
“The number of patient deaths and frequency of suffering from HAI is unacceptable and unconscionable”
ONEighty oC’s proprietary processes have been proven to sterilize anthrax by disrupting the extremely stable anthrax spores and destroying the bacteria’s DNA chain. Anthrax is an endospore at the Mt. Everest pinnacle of resistance to sterilization and can survive in the environment for decades. Lethal bio-pathogens such as MRSA, ricin, prions, CRE and C. diff are generally considered to be less resistant to sterilization than anthrax. These super bugs, biofilms, viruses, proteins and other hazardous substances can cause widespread infections.
Estimates by the U.S. Department of Health and Human Services state that 1 in every 20 hospital patients develops a hospital acquired infection (HAI), costing the U.S. healthcare system billions of dollars each year and leading to thousands of deaths. MRSA alone contributes to more than 100,000 deaths in the U.S. and the U.K. annually.
“The number of patient deaths and frequency of suffering from HAI is unacceptable and unconscionable,” said David Smith, Chairman/CEO. “By introducing a novel, high-performance sterilization technology and new product solutions into hospitals and medical institutions, we are serving the U.S. healthcare system by confronting significant cost pressures, unreimbursed patient readmissions from HAI, and the requirement to improve sustainability levels in hospital operations.”
As demonstrated by the recent cases of exposure to CJD, a fatal brain disease, routine sterilization systems are unable to destroy the infection prions that cause CJD. Many patients must now wait for years to determine if they have become infected from contaminated surgical equipment that was processed by standard sterilization procedures. This incident and many other medical reports reveal widespread failures in infection control that drive unsustainable patient re-admissions due to HAI.
“Our systems use a proprietary combination of NASA-developed technologies that were refined through a multi-year engineering process that involved the development of several system prototypes and customized algorithms. The system energies are focused to break pathogenic DNA directly to achieve superior sterilization results,” Smith concluded.
To date, the Company’s technology has been commercialized and sold as a system for high security applications in both public and private sectors by sterilizing anthrax and other hazardous bio-pathogens sent via the mail. A newly designed system with optimized performance is being completed to fulfill existing purchase orders.
About ONEighty oC Technologies Corporation
ONEighty oC Technologies’ mission is to develop and produce superior product solutions in the health and security markets to reduce costs and improve patients’ health and citizens’security. The Company owns a commercialized and patented technology platform designed to break the DNA chain of lethal bio-pathogens. Multiple product applications of the Company’s technology platform target global, under-served health and security markets. The Company’s systems have the potential to save medical institutions hundreds of millions of dollars.
For more information about the Company and its technology platform, please visit:
ONEighty oC Technologies believes that this press release contains forward-looking statements. Such forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause results to differ materially from the forward-looking statements. The Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.